Table 1.
Multivariate analysis (BBCC validation TMA) of recurrence-free survival, adjusted for pT, pN, Grading, ER, PR, HER2 and SERBP1
| Characteristic | N | Adjusted Hazard Ratio | 95% CI | p-value | |||
|---|---|---|---|---|---|---|---|
| pTa |
1 |
312 |
1 |
|
|
|
|
| |
2 |
227 |
1.85 |
1.10 |
to |
3.10 |
0.02 |
| |
3 |
29 |
3.48 |
1.64 |
to |
7.37 |
0.001 |
| |
4 |
37 |
7.25 |
3.81 |
to |
13.80 |
1.7E-09 |
| pNa |
0 |
351 |
1 |
|
|
|
|
| |
1 |
254 |
2.41 |
1.47 |
to |
3.94 |
0.0005 |
| Grading |
1 |
49 |
1 |
|
|
|
|
| |
2 |
361 |
1.40 |
0.43 |
to |
4.57 |
0.57 |
| |
3 |
195 |
1.95 |
0.57 |
to |
6.64 |
0.29 |
| ER |
Neg |
143 |
1 |
|
|
|
|
| |
Pos |
462 |
1.19 |
0.63 |
to |
2.24 |
0.59 |
| PR |
Neg |
205 |
1 |
|
|
|
|
| |
pos |
400 |
0.58 |
0.33 |
to |
1.04 |
0.067 |
| HER2 |
Neg |
511 |
1 |
|
|
|
|
| |
pos |
94 |
1.06 |
0.60 |
to |
1.85 |
0.85 |
| SERBP1 |
IRS 0-2 |
91 |
1 |
|
|
|
|
| IRS 3-12 | 514 | 0.59 | 0.35 | to | 0.98 | 0.039 | |
aAccording to Sobin LH, Wittekind CH: UICC: TNM Classification of Malignant Tumours. 6th edition, New York: Wiley; 2002 [27].
pT: Pathological assessment of the primary tumour.
pN: Pathological assessment of the regional lymph nodes.
CI: Confidence interval.